Psychopharmacology

Subtopic:

Antipsychotics

Antipsychotics are a category of prescription medications within psychiatry used for the treatment of psychosis.

Antipsychotic medications are psychiatric drugs employed in the management of mental illnesses characterized by a disconnect from reality, distortions in perception, impaired thinking abilities, and reduced emotional expression.

These medications are officially approved for addressing specific mental health conditions where psychotic experiences are a prominent feature of the symptom profile.

Antipsychotics, also known as neuroleptics, constitute a class of psychotropic drugs primarily intended to manage psychosis. Schizophrenia is the main target condition, but they are also utilized across a spectrum of psychotic disorders, including manic episodes that present with psychotic symptoms.

Furthermore, antipsychotics are used in conjunction with mood stabilizers in the treatment of bipolar disorder. They also play a role in managing psychosis associated with depressive disorders, bipolar affective disorder, and psychosis linked to Alzheimer’s disease.

Introduction to Psychosis

Psychosis is a term encompassing a range of mental disorders that share one or more of the following key features:

  1. Impaired Information Processing: A reduced and distorted capacity to process information accurately and form logical conclusions based on reality.

  2. Hallucinations: Sensory experiences occurring in the absence of external stimuli, most frequently auditory (hearing voices) or visual (seeing things), but can also involve tactile (touch) or olfactory (smell) senses.

  3. Delusions: Fixed, false beliefs that are firmly held despite contradictory evidence and are not in line with cultural or educational background.

  4. Disorganized Thought and Speech: Incoherent speech patterns or a noticeable loosening of associations between thoughts, making communication difficult to follow.

  5. Abnormal Motor Behavior: Catatonic behavior (marked decrease in reactivity to the environment or purposeless overactivity) or generally disorganized behavior that is inappropriate or unpredictable.

  6. Aggression or Violence: In some cases, psychotic states can be associated with increased agitation, aggression, or violent behavior.

Antipsychotic medications are effective in reducing these symptoms, irrespective of the specific underlying cause or combination of causes of the psychosis.

Conditions frequently associated with psychosis include:

  • Schizophrenia

  • Mania

  • Bipolar disorder

  • Schizoaffective disorder

  • Severe Depression

  • Alcohol withdrawal syndrome

  • Delirium

Factors Potentially Contributing to Psychosis:
  1. Genetic Predisposition: Inherited genetic factors can increase vulnerability to psychotic disorders.

  2. Alcohol Use Disorders: Chronic alcoholism and alcohol withdrawal can induce psychosis.

  3. Brain Tumors: Tumors in the brain can sometimes cause psychotic symptoms depending on their location and impact.

  4. Traumatic Brain Injuries: Head injuries can, in some instances, lead to the development of psychosis.

  5. Central Nervous System Stimulants: Substances that stimulate the central nervous system, such as cocaine, can trigger psychosis.

Psychosis-Inducing Substances

  1. Levodopa: A medication used to treat Parkinson’s disease, can paradoxically induce psychosis in some individuals.

  2. CNS Stimulants: Stimulant drugs like:

    • Cocaine

    • Amphetamines

    • Khat, cathinone, and methcathinone (psychoactive substances derived from the khat plant)

  3. Other Substances:

    • Apomorphine (used in Parkinson’s and erectile dysfunction treatment)

    • Phencyclidine (PCP) – an illicit dissociative drug

Neurotransmitters

Neurotransmitters are chemical messengers in the brain, and can be broadly classified by their primary effect:

  1. Excitatory Neurotransmitters: These neurotransmitters stimulate neuronal activity. Examples include:

    • Dopamine

    • Adrenaline (epinephrine)

    • Noradrenaline (norepinephrine)

    • Serotonin (5-HT – 5-hydroxytryptamine)

  2. Inhibitory Neurotransmitters: These neurotransmitters reduce neuronal activity. A key example is:

    • Gama Amino Butyric acid (GABA)

SCHIZOPHRENIA

Schizophrenia is a persistent mental illness characterized by disordered thinking and a detachment from reality. It is classified as a psychotic disorder.

In essence, schizophrenia is a mental condition defined by:

  • Personality Alterations: Changes in typical personality traits leading to difficulties in interpersonal relationships.

  • Mood Disturbance: Disrupted emotional state and regulation.

  • Impaired Environmental Perception: Difficulty in accurately understanding and interpreting the surrounding environment.

The onset of schizophrenic symptoms commonly occurs during adolescence or in early adulthood.

It is theorized that schizophrenia is associated with an overactivity of dopamine pathways in the brain. Excessive dopamine release is believed to cause overstimulation of brain cells, resulting in the characteristic abnormal behaviors and experiences of schizophrenia.

DOPAMINE

Dopamine (DA) is a crucial neurotransmitter within the brain.

Effects of Dopamine

Dopamine plays several significant roles in brain function:

  • Motor Function: Dopamine is essential for the initiation and modulation of movement.

  • Reward and Cognition: It is involved in reinforcement learning, reward pathways, and various cognitive functions, including attention and working memory.

  • Prolactin Regulation: Dopamine normally inhibits the release of prolactin, a hormone involved in lactation.

  • Emesis (Vomiting): Dopamine pathways play a role in the vomiting reflex.

  • Thermoregulation: Dopamine contributes to the regulation of body temperature.

  • Appetite Control: Dopamine can influence appetite and food intake.

Signs and Symptoms of Schizophrenia

Schizophrenic symptoms are broadly categorized into two main types:

  • Positive Symptoms: These symptoms reflect an excess or distortion of normal functions. They are often described as “psychotic” symptoms.

  • Negative Symptoms: These symptoms reflect a deficit or diminution of normal functions. They indicate a reduction in typical emotional and behavioral responses.

Positive and Negative Symptoms of Schizophrenia

Positive SymptomsNegative Symptoms
Hallucinations (e.g., hearing voices, seeing things)Social withdrawal
Delusions (Fixed false beliefs)Emotional withdrawal
Disorganized speechLack of motivation (avolition)
Agitation (increased motor activity)Poverty of speech (alogia)
 Flat affect (blunted emotions)
 Poor self-care and hygiene

Understanding Symptom Balance:

  • Positive Symptoms and Stimulation: Positive symptoms are often associated with increased brain activity, particularly in dopamine pathways. Drugs that depress brain activity (like antipsychotics) are used to reduce these symptoms. However, using depressants can potentially worsen negative symptoms.

  • Negative Symptoms and Depression (of Function): Negative symptoms are linked to a decrease in certain brain functions, possibly involving serotonin pathways. Historically, attempts to treat negative symptoms with stimulant-like drugs could exacerbate positive symptoms.

The clinical presentation of schizophrenia is highly variable, especially in the relative prominence of positive versus negative symptoms.

Positive symptoms are generally linked to increased activity in dopamine pathways, while negative symptoms are thought to be associated with decreased activity in serotonin pathways and potentially other neurotransmitter systems.

Key path ways that afftected by  dopamine in the brain

Dopamine neurotransmission in the brain is organized into several key pathways, each playing a distinct role in both normal function and in the pathophysiology of psychosis. These pathways are:

  1. Mesocortical Pathway:

    • This pathway originates in the brainstem and projects to the cerebral cortex, specifically the prefrontal cortex.

    • It is thought to be crucial for cognitive functions and negative symptoms of psychosis.

    • In individuals experiencing psychosis, dysfunction in this pathway, specifically reduced dopamine activity, is hypothesized to contribute to negative symptoms such as social withdrawal, lack of motivation, and cognitive impairments like deficits in executive functions.

  2. Mesolimbic Pathway:

    • This pathway projects from dopaminergic neurons in the ventral tegmental area (VTA) of the brainstem to the limbic system, which includes structures like the nucleus accumbens.

    • It is strongly implicated in the positive symptoms of psychosis, such as hallucinations, delusions, and thought disorders.

    • In psychotic disorders, excessive dopamine activity in this pathway is believed to be a primary driver of these positive symptoms.

  3. Nigrostriatal Pathway:

    • This pathway extends from dopamine-producing cells in the substantia nigra to the basal ganglia (striatum).

    • Its primary function is in regulating movement. Dopamine in this pathway normally inhibits the activity of acetylcholine.

    • Reduced dopamine activity (hypoactivity) in the nigrostriatal pathway can lead to Parkinsonian-like movement disorders, including rigidity, bradykinesia (slowed movement), tremors, akathisia (restlessness), and dystonia (muscle spasms).

  4. Tuberoinfundibular Pathway:

    • This pathway connects the hypothalamus to the anterior pituitary gland.

    • Dopamine in this pathway acts to inhibit or regulate prolactin release from the anterior pituitary.

    • Blockade of dopamine receptors in this pathway by antipsychotic drugs can result in hyperprolactinemia (elevated prolactin levels). This can manifest clinically as gynecomastia (breast enlargement in males), galactorrhea (milk production in non-nursing individuals), decreased libido, and menstrual irregularities in women.

General Mechanisms of Action of Antipsychotics

The primary mechanism by which antipsychotic medications exert their therapeutic effects involves blocking dopamine receptors and related neurotransmission pathways in the brain.

  • Dopamine Receptor Blockade: A prevailing theory in psychosis suggests that an overproduction or dysregulation of dopamine in certain brain pathways contributes to psychotic symptoms. Antipsychotic drugs primarily function as dopamine receptor antagonists, effectively blocking dopamine’s action at these receptors.

  • Reduction of Dopaminergic Signaling: By blocking dopamine receptors, antipsychotics reduce the flow of dopamine-mediated messages in the brain. This dampening of dopamine signaling is thought to be the basis for the reduction of psychotic symptoms.

  • Targeting Mesolimbic and Mesocortical Systems: Antipsychotics often exert their therapeutic effects through blockade of dopamine and/or serotonin 5-HT2 receptors, particularly in the mesolimbic pathway. This action is crucial for alleviating positive symptoms.

  • Serotonin Receptor Modulation: Some antipsychotics also exhibit 5-HT2 receptor antagonism. Similar to alpha-2 adrenergic receptor blockade in the autonomic nervous system, 5-HT2 receptor blockade can potentially increase serotonin release.

  • Additional Receptor Interactions: Beyond dopamine and serotonin receptors, many antipsychotics also interact with other receptor types, including cholinergic, adrenergic, and histaminergic receptors. Many of the undesirable side effects associated with antipsychotic medications are attributed to these off-target actions at these other receptor systems.

Pharmacokinetic Properties
  • Absorption and Distribution:

    • Antipsychotics are generally well absorbed following oral administration but absorption is often incomplete.

    • They undergo significant first-pass metabolism in the liver, reducing bioavailability.

    • Typical bioavailability ranges from 25% to 65%.

    • They are characterized by high lipid solubility, facilitating entry into the brain.

    • A high degree of plasma protein binding (92-98%) is common.

    • They exhibit large volumes of distribution (>7 L/Kg), indicating wide tissue penetration.

    • Antipsychotics are known for slow elimination from the body.

    • Their duration of action often exceeds what would be predicted based on half-life, and clinical relapse can occur weeks after drug discontinuation, which may be due to the presence of active metabolites.

  • Metabolism:

    • Antipsychotics are almost completely metabolized, primarily in the liver.

    • Many antipsychotics are metabolized into active metabolites, although these metabolites do not typically play a major role in the overall therapeutic effect. A notable exception is thioridazine, where its metabolite, mesoridazine, is more potent and contributes significantly to the drug’s therapeutic action.

  • Excretion:

    • Due to extensive metabolism, very little antipsychotic drug is excreted unchanged in the urine.

    • The elimination half-life typically ranges from 10 to 24 hours for most antipsychotics.